An open trial to evaluate the efficacy and tolerability of ziprasidone IM [intramuscular] and oral in patients with psychosis and acute agitation.
Phase of Trial: Phase III
Latest Information Update: 28 Jul 2011
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Acronyms BIZET
- Sponsors Pfizer
- 01 Sep 2006 New trial record.